Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks the cells that produce insulin—a ...
In 2024 Stephen Rich and his colleagues published a study in which they assessed the genetic risk of developing type 1 ...
News-Medical.Net on MSN
Discovery of vascular-associated fibroblastic cells opens new path for diabetes treatment
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks the cells that produce insulin-a ...
HIGH POINT, N.C., Sept. 16, 2020 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT) today announced it will deliver two oral presentations emphasizing the potential of TTP399 as an oral ...
Announcement of a podium presentation at a prestigious symposium, showcasing innovative research in cell therapy for type 1 diabetes. Presentation features promising clinical data on UP421, a novel ...
When kindergartners had questions about their classmate’s Type 1 diabetes, this fourth-grader stepped in to teach them.
Please provide your email address to receive an email when new articles are posted on . Semaglutide improved time in glycemic range in patients with type 1 diabetes and obesity using an automated ...
“It’s well-established that people with type 1 diabetes (T1D) and chronic kidney disease (CKD) are at high risk of progression to kidney failure and cardiovascular events due to poor glycemic control, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback